The invention relates to modified release pharmaceutical compositions of memantine or pharmaceutically acceptable salts thereof. The compositions of invention are stable possessing improved formulation characteristics and also provide extended therapeutically effective plasma levels over twenty four hours period. The invention also relates to processes of making such compositions.